
John P. Nguyen
Examiner (ID: 7508, Phone: (571)270-5877 , Office: P/1619 )
| Most Active Art Unit | 1619 |
| Art Unit(s) | 1619 |
| Total Applications | 486 |
| Issued Applications | 194 |
| Pending Applications | 62 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18192562
[patent_doc_number] => 20230046081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => SYNERGISTIC ACTIVITY OF NOVEL COMPOUNDS AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 17/874526
[patent_app_country] => US
[patent_app_date] => 2022-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17874526
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/874526 | SYNERGISTIC ACTIVITY OF NOVEL COMPOUNDS AGAINST PLANKTONIC AND BIOFILM CELLS OF CLINICALLY RELEVANT PATHOGENS | Jul 26, 2022 | Pending |
Array
(
[id] => 18240428
[patent_doc_number] => 20230072739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => COMBINATION THERAPY TREATMENT USING TRANSDERMAL DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/809191
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809191
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809191 | COMBINATION THERAPY TREATMENT USING TRANSDERMAL DELIVERY SYSTEM | Jun 26, 2022 | Abandoned |
Array
(
[id] => 17911247
[patent_doc_number] => 20220313642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM
[patent_app_type] => utility
[patent_app_number] => 17/847951
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847951 | TYROSINE DERIVATIVES AND COMPOSITIONS COMPRISING THEM | Jun 22, 2022 | Abandoned |
Array
(
[id] => 17881161
[patent_doc_number] => 20220296638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHOD OF TREATING MIGRAINES AND HEADACHES
[patent_app_type] => utility
[patent_app_number] => 17/835805
[patent_app_country] => US
[patent_app_date] => 2022-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/835805 | Method of treating migraines and headaches | Jun 7, 2022 | Issued |
Array
(
[id] => 18034512
[patent_doc_number] => 20220378727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/743271
[patent_app_country] => US
[patent_app_date] => 2022-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743271 | DRY POWDER FORMULATIONS OF TAMIBAROTENE FOR PULMONARY AND INTRANASAL DELIVERY | May 11, 2022 | Abandoned |
Array
(
[id] => 19242028
[patent_doc_number] => 12012447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-18
[patent_title] => Compositions and methods for reducing at least one symptom of human allergy to cats
[patent_app_type] => utility
[patent_app_number] => 17/731403
[patent_app_country] => US
[patent_app_date] => 2022-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4383
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17731403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/731403 | Compositions and methods for reducing at least one symptom of human allergy to cats | Apr 27, 2022 | Issued |
Array
(
[id] => 20200344
[patent_doc_number] => 12403109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Sotalol hydrochloride dosing
[patent_app_type] => utility
[patent_app_number] => 17/725189
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1709
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725189
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725189 | Sotalol hydrochloride dosing | Apr 19, 2022 | Issued |
Array
(
[id] => 17641770
[patent_doc_number] => 20220169508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/671540
[patent_app_country] => US
[patent_app_date] => 2022-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17671540
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/671540 | PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF | Feb 13, 2022 | Abandoned |
Array
(
[id] => 18747138
[patent_doc_number] => 11806429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Film formulations containing dexmedetomidine and methods of producing them
[patent_app_type] => utility
[patent_app_number] => 17/579914
[patent_app_country] => US
[patent_app_date] => 2022-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32115
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579914 | Film formulations containing dexmedetomidine and methods of producing them | Jan 19, 2022 | Issued |
Array
(
[id] => 18970373
[patent_doc_number] => 20240050465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY
[patent_app_type] => utility
[patent_app_number] => 18/264815
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264815
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264815 | HYDROGEN WATER FOR PREVENTION OF ALCOHOLIC HEPATOPATHY | Jan 10, 2022 | Pending |
Array
(
[id] => 18994660
[patent_doc_number] => 11911477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Use of fructose in preparing drug for treating ischemic injury
[patent_app_type] => utility
[patent_app_number] => 17/646935
[patent_app_country] => US
[patent_app_date] => 2022-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 29
[patent_no_of_words] => 4480
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646935
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/646935 | Use of fructose in preparing drug for treating ischemic injury | Jan 3, 2022 | Issued |
Array
(
[id] => 20293828
[patent_doc_number] => 20250319071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/269421
[patent_app_country] => US
[patent_app_date] => 2021-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269421
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/269421 | PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | Dec 28, 2021 | Pending |
Array
(
[id] => 17625614
[patent_doc_number] => 20220160629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM
[patent_app_type] => utility
[patent_app_number] => 17/560423
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560423 | Film formulations containing dexmedetomidine and methods of producing them | Dec 22, 2021 | Issued |
Array
(
[id] => 17996625
[patent_doc_number] => 11497711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => Film formulations containing dexmedetomidine and methods of producing them
[patent_app_type] => utility
[patent_app_number] => 17/560392
[patent_app_country] => US
[patent_app_date] => 2021-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32144
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17560392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/560392 | Film formulations containing dexmedetomidine and methods of producing them | Dec 22, 2021 | Issued |
Array
(
[id] => 17685828
[patent_doc_number] => 20220193120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR MAINTAINING LUNG FUNCTION IN HUMAN LUNG CANCER AND/OR IMPROVING REDUCTION IN LUNG FUNCTION ATTRIBUTED TO HUMAN LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 17/552193
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552193
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552193 | MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR MAINTAINING LUNG FUNCTION IN HUMAN LUNG CANCER AND/OR IMPROVING REDUCTION IN LUNG FUNCTION ATTRIBUTED TO HUMAN LUNG CANCER | Dec 14, 2021 | Abandoned |
Array
(
[id] => 19608026
[patent_doc_number] => 12156885
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Methods and compositions for treating heart conditions
[patent_app_type] => utility
[patent_app_number] => 17/541533
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5297
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541533 | Methods and compositions for treating heart conditions | Dec 2, 2021 | Issued |
Array
(
[id] => 17640622
[patent_doc_number] => 20220168360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/539595
[patent_app_country] => US
[patent_app_date] => 2021-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539595
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/539595 | COMPOSITIONS, DEVICES, AND METHODS FOR TREATING RESPIRATORY DISORDERS | Nov 30, 2021 | Pending |
Array
(
[id] => 17640453
[patent_doc_number] => 20220168191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => PROCESS FOR THE PREPARATION OF A READY-TO-USE, COSMETIC, FLOWABLE DETERGENT
[patent_app_type] => utility
[patent_app_number] => 17/537635
[patent_app_country] => US
[patent_app_date] => 2021-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537635
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/537635 | Process for the preparation of a ready-to-use, cosmetic, flowable detergent | Nov 29, 2021 | Issued |
Array
(
[id] => 18970420
[patent_doc_number] => 20240050512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => REDUCTION OF VIRAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/265981
[patent_app_country] => US
[patent_app_date] => 2021-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265981
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265981 | REDUCTION OF VIRAL INFECTIONS | Nov 24, 2021 | Pending |
Array
(
[id] => 19608027
[patent_doc_number] => 12156886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-03
[patent_title] => Methods of increasing blood oxygen saturation
[patent_app_type] => utility
[patent_app_number] => 17/525841
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 17144
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525841 | Methods of increasing blood oxygen saturation | Nov 11, 2021 | Issued |